<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01388036</url>
  </required_header>
  <id_info>
    <org_study_id>397-27.05.05</org_study_id>
    <nct_id>NCT01388036</nct_id>
  </id_info>
  <brief_title>Genetic Determinants of Hemodynamic Response to Esmolol</brief_title>
  <official_title>A Study in Healthy Subjects to Evaluate Genetic Determinants of the Variability in Hemodynamic Response to Esmolol</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hadassah Medical Organization</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hadassah Medical Organization</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Beta 1 Adrenergic antagonists (beta blockers) have major role in the treatment of CHF, IHD
      and hypertension. However, there is large interindividual variability in the response to beta
      blockers.

      The hypothesis underlying this study is that genetic differences between individuals will
      determine the individual response to esmolol, a betablocker that is administered
      intravenously. Esmolol will be administered intravenously to healthy volunteers, and the
      effects on heart rate and blood pressure will be monitored. In addition, we will measure
      plasma renin activity and plasma levels of norepinephrine.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>July 2011</start_date>
  <primary_completion_date type="Anticipated">May 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in heart rate during exercise</measure>
    <time_frame>3 hours</time_frame>
    <description>continous measurement of heart rate</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>change in systolic blood pressure during exercise</measure>
    <time_frame>3 hours</time_frame>
    <description>measurement of systolic blood pressure every 5 minutes</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Decrease in Heart Rate Below Baseline Value</condition>
  <arm_group>
    <arm_group_label>esmolol infusion</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>infusion of esmolol during rest and exercise</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>esmolol</intervention_name>
    <description>consecutive infusions of esmolol and normal saline (placebo)</description>
    <arm_group_label>esmolol infusion</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  healthy male and female

          -  able to understand and sign informed consent

        Exclusion Criteria:

          -  consumption of any medication

          -  bradycardia &lt;50 BPM

          -  hypersensitivity to beta blockers
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Mordechai Muszkat, MD</last_name>
    <phone>972-2-6777111</phone>
    <phone_ext>73793</phone_ext>
    <email>muszkatm@hadassah.org.il</email>
  </overall_contact>
  <location>
    <facility>
      <name>Hadassah Hebrew University Medical Center</name>
      <address>
        <city>Jerusalem</city>
        <zip>91120</zip>
        <country>Israel</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mordechai Muszkat, MD</last_name>
      <phone>972-2-6777111</phone>
      <phone_ext>73793</phone_ext>
      <email>muszkatm@hadassah.org.il</email>
    </contact>
    <investigator>
      <last_name>Mordechai Muszkat, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <verification_date>July 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 3, 2011</study_first_submitted>
  <study_first_submitted_qc>July 5, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 6, 2011</study_first_posted>
  <last_update_submitted>July 5, 2011</last_update_submitted>
  <last_update_submitted_qc>July 5, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 6, 2011</last_update_posted>
  <responsible_party>
    <name_title>Mordechai Muszkat, MD</name_title>
    <organization>Hadassah- Hebrew University Medical Center</organization>
  </responsible_party>
  <keyword>heart rate</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Bradycardia</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Esmolol</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

